14 In colorectal cancer, a follow-up study of 60 patients who received intraoperative DEX (1 μg/kg loading dose, followed by 0.3 μg·kg −1 ·h −1 infusion) showed a trend toward improved overall and disease-free survival, although these differences were not statistically significant.
← all excerpts
Immunomodulatory potential of dexmedetomidine in perioperative pain management for patients with cancer.
1
—
—